In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zimmer pays $13.35bn in cash and stock for Biomet

Executive Summary

Positioning itself to become a top competitor in the $45bn musculoskeletal market, Zimmer Holdings Inc. bought public orthopedic device maker Biomet Inc. for $13.35bn--$10.35bn in cash and $3bn in Zimmer stock. Zimmer plans to refinance some of its own debt, including an existing $250mm in notes due 2014, in addition to certain Biomet debt.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Payment Includes Cash
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register